BERLIN (Reuters) – Germany’s vaccine commission stuck to its recommendation on Thursday that people aged under 60 who have received one shot of AstraZeneca’s COVID-19 vaccine should receive an mRNA vaccine as their second dose.
The commission, known as STIKO, said the second dose should be administered twelve weeks after the AstraZeneca shot.
Two mRNA vaccines, one from Pfizer/BioNTech and one from Moderna, are currently approved for use in Germany.
(Reporting by Caroline Copley, editing by Thomas Escritt)
